fibrinogen has been researched along with Chronic Hepatitis C in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abed, SY; El-Mesery, M; El-Mowafy, M; Elgaml, A; Youssef, LF | 1 |
Allison, RD; Alter, HJ; De Giorgi, V; Grandinetti, T; Salam, KA; Wang, RY | 1 |
Glavaš, S; Gornjaković, S; Mehmedović, A; Mesihović, R; Papović, V; Saray, A; Vanis, N; Vukobrat-Bijedić, Z | 1 |
Alyan, O; Astan, R; Celebi, AS; Deveci, B; Ilkay, E; Kacmaz, F; Ozdemir, O | 1 |
Adeyi, OA; Clark, DA; Foerster, K; Grant, DR; Heathcote, EJ; Helmy, A; Khattar, R; Levy, GA; Phillips, MJ; Renner, EL; Selzner, N; Shalev, I; Wong, KM; Wong, PY; Zhu, Y | 1 |
Gornjakovic, S; Mesihovic, R; Prohic, D; Saray, A; Vanis, N | 1 |
Ihara, A; Nakashima, M; Yasui, M | 1 |
Fujioka, T; Iwasaki, T; Kurosaki, Y; Okano, T; Okazaki, T; Taniguchi, M; Yamazaki, K | 1 |
Imazeki, F; Kanai, F; Kuga, T; Nakajima, A; Nishimura, M; Noda, K; Nomura, F; Seimiya, M; Sogawa, K; Takizawa, H; Tomonaga, T; Tsutsumi, M; Umemura, H; Yokosuka, O; Yoneda, M | 1 |
Bonetti, B; Capasso, M; Di Muzio, A; Panzeri, L; Pizzigallo, E; Rizzuto, N; Uncini, A | 1 |
Dymek, G; Kotschy, M; Michalska, K; Szaflarska-Popławska, A | 1 |
Başkol, M; Eser, B; Gürsoy, S; Güven, K; Ozbakir, O; Soyuer, I; Torun, E; Yücesoy, M; Yurci, A | 1 |
Abdel Gader, AG; Al Faleh, FZ; Al Ghumlas, AK | 1 |
13 other study(ies) available for fibrinogen and Chronic Hepatitis C
Article | Year |
---|---|
Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
Topics: Aspartate Aminotransferases; Bilirubin; Carcinoma, Hepatocellular; Egypt; Fas Ligand Protein; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-gamma; Liver Neoplasms; Middle Aged; Serum Albumin; Solubility | 2017 |
Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.
Topics: Antigen-Antibody Complex; B-Lymphocytes; Cell Line, Tumor; Complement System Proteins; Erythrocytes; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Kinetics; Receptors, Complement 3b; Receptors, Complement 3d | 2018 |
Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C.
Topics: Adult; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemostasis; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Partial Thromboplastin Time; Polyethylene Glycols; Protein C; Protein S; Prothrombin Time; Recombinant Proteins; Ribavirin | 2013 |
Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Linear Models; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Assessment; Risk Factors; Severity of Illness Index; Turkey | 2008 |
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Hepatitis C, Chronic; Humans; Liver Diseases, Alcoholic; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Severity of Illness Index | 2010 |
Clinical significance of haemostatic tests in chronic liver disease.
Topics: Adult; Antithrombin III; Biomarkers; Blood Coagulation Tests; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; International Normalized Ratio; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Protein C | 2012 |
Fibrinogen salvage during DF Thermo using Evaflux-5A plasma fractionators.
Topics: Animals; Cattle; Equipment Design; Fibrinogen; Filtration; Hepatitis C, Chronic; In Vitro Techniques; Membranes, Artificial; Plasmapheresis; Temperature; Viscosity | 2012 |
Cysteine analog breaks cryoprecipitate associated with chronic hepatitis C.
Topics: alpha-2-HS-Glycoprotein; Cryoglobulins; Cysteine; Disulfides; Factor VIII; Fibrinogen; Hepatitis C, Chronic; Humans | 2013 |
Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus.
Topics: Adult; Aged; Biomarkers; Blood Specimen Collection; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Reference Values; ROC Curve; Temperature; Time Factors | 2013 |
Hepatitis C virus infection and myositis: a virus localization study.
Topics: Aged; Female; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Immunoglobulin G; Immunohistochemistry; In Situ Hybridization; Major Histocompatibility Complex; Microscopy, Electron; Myositis; Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Viral Nonstructural Proteins | 2003 |
[Activation of fibrynolysis in children with chronic B or C hepatitis].
Topics: Adolescent; alpha-2-Antiplasmin; Antifibrinolytic Agents; Case-Control Studies; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Male; Plasminogen Activator Inhibitor 1; Poland; Tissue Plasminogen Activator | 2004 |
Importance of anticoagulant proteins in chronic liver diseases.
Topics: Adult; Aged; Antithrombins; Bilirubin; Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Middle Aged; Protein C; Protein S; Serum Albumin; Severity of Illness Index | 2005 |
Natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis.
Topics: Adult; Antiviral Agents; Biomarkers; Case-Control Studies; Female; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatocytes; Humans; Interferon-alpha; Liver; Male; Middle Aged; Protein S; Thrombin Time | 2008 |